Hasmukh Jain
About
Hasmukh Jain is a scholar working on Oncology, Hematology and Pathology and Forensic Medicine.
According to data from OpenAlex, Hasmukh Jain has authored 79 papers receiving a total of 412 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 26 papers in Hematology and 25 papers in Pathology and Forensic Medicine. Recurrent topics in Hasmukh Jain's work include Lymphoma Diagnosis and Treatment (24 papers), Acute Lymphoblastic Leukemia research (16 papers) and Chronic Lymphocytic Leukemia Research (13 papers). Hasmukh Jain is often cited by papers focused on Lymphoma Diagnosis and Treatment (24 papers), Acute Lymphoblastic Leukemia research (16 papers) and Chronic Lymphocytic Leukemia Research (13 papers). Hasmukh Jain collaborates with scholars based in India, United States and Brazil. Hasmukh Jain's co-authors include Manju Sengar, Bhausaheb Bagal, Nikhil Patkar, Rajesh Sharma, Sumeet Gujral, Prashant Tembhare, Papagudi Ganesan Subramanian, Navin Khattry, Prateek Bhatia and Lingaraj Nayak and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Annals of Oncology.
In The Last Decade
Hasmukh Jain
64 papers receiving 402 citations
Peers
Hasmukh Jain
Tianyou Wang China
Ladislav Jebavý Czechia
Áurea Lima Portugal
Mohammad Vaezi Iran
Edyta Szymańska Poland
Sunday Ocheni Nigeria
Geetha Narayanan India
Riad El Fakih Saudi Arabia
Anand Patel United States
Yoo Jin Lee South Korea
Citations per year, relative to Hasmukh Jain Hasmukh Jain (= 1×)
peers
Tianyou Wang
Countries citing papers authored by Hasmukh Jain
Since
Specialization
Citations
This map shows the geographic impact of Hasmukh Jain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hasmukh Jain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hasmukh Jain more than expected).
Fields of papers citing papers by Hasmukh Jain
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Hasmukh Jain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hasmukh Jain. The network helps show where Hasmukh Jain may publish in the future.
Co-authorship network of co-authors of Hasmukh Jain
This figure shows the co-authorship network connecting the top 25 collaborators of Hasmukh Jain. A scholar is included among the top collaborators of Hasmukh Jain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hasmukh Jain. Hasmukh Jain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Goda, Jayant Sastri, Atharva Karulkar, Nirali N. Shah, et al.. (2024). Development of a Novel Humanized BCMA-Directed CAR for Multiple Myeloma: Robust Activity and Low Toxicity in Preclinical Studies. Blood. 144(Supplement 1). 4809–4809.
2.
Desai, P. B., Bhausaheb Bagal, Chetan Dhamne, et al.. (2023). Navigating the neutropenic abyss with granulocyte transfusions: Retrospective single‐center analysis of effectiveness and safety in India. Journal of Clinical Apheresis. 38(6). 703–710.
3.
Jain, Hasmukh, Sanjay Biswas, Lingaraj Nayak, et al.. (2023). Hepatitis B Reactivation without Hepatitis Is a Common Event in Adolescent/Adult Patients of Acute Lymphoblastic Leukemia with Occult Hepatitis B (OHBI) Treated on Pediatric Protocols and Warrants Prophylactic Antivirals: A Prospective Cohort Study. Blood. 142(Supplement 1). 1459–1459.
4.
Sengar, Manju, Hasmukh Jain, Murari Gurjar, et al.. (2023). A Prospective Study to Evaluate the Effect of Therapeutic Drug Monitoring-Based Posaconazole Prophylaxis on Invasive Fungal Infection Rate During Acute Myeloid Leukemia Induction Therapy. Indian Journal of Hematology and Blood Transfusion. 40(2). 204–212.
5.
Jain, Hasmukh, et al.. (2023). AML-282 Venetoclax Upregulates Mitochondrial Stress Response to Overcome the Resistance to Arsenic Trioxide in Acute Promyelocytic Leukemia. Clinical Lymphoma Myeloma & Leukemia. 23. S285–S285.
6.
Sengar, Manju, Hasmukh Jain, Tanuja Shet, et al.. (2022). Phase II trial of a novel chemotherapy regimen CVEP (cyclophosphamide, vinblastine, etoposide and prednisolone) for acquired immunodeficiency syndrome (AIDS) ‐associated lymphomas. British Journal of Haematology. 200(4). 429–439.
7.
Tembhare, Prashant, Gaurav Chatterjee, Sitaram Ghogale, et al.. (2022). Critical Role of Flow Cytometric Immunophenotyping in the Diagnosis, Subtyping, and Staging of T-Cell/NK-Cell Non-Hodgkin’s Lymphoma in Real-World Practice: A Study of 232 Cases From a Tertiary Cancer Center in India. Frontiers in Oncology. 12. 779230–779230.
8.
Jain, Hasmukh, Manju Sengar, Prashant Tembhare, et al.. (2021). Bortezomib and rituximab in de novo adolescent/adult CD20-positive, Ph-negative pre-B-cell acute lymphoblastic leukemia. Blood Advances. 5(17). 3436–3444.
9.
Jain, Hasmukh, Lingaraj Nayak, Prashant Tembhare, et al.. (2021). Outcomes and prognostic factors in adolescents and young adults with ALL treated with a modified BFM-90 protocol. Blood Advances. 5(5). 1178–1193.
10.
Jain, Hasmukh, Akhil Kapoor, Manju Sengar, et al.. (2021). Outcomes of Patients with Primary Mediastinal B-Cell Lymphoma Treated with Dose Adjusted R-EPOCH Regimen: A Single Centre Experience. Indian Journal of Hematology and Blood Transfusion. 37(3). 379–385.
11.
Sengar, Manju, et al.. (2021). Feasibility of Delivering High-Dose Methotrexate in Adolescent and Adult All Patients: A Retrospective Study. Indian Journal of Hematology and Blood Transfusion. 38(4). 638–642.
12.
Chan, Raymond J., Megan Crichton, Fiona Crawford‐Williams, et al.. (2021). The efficacy, challenges, and facilitators of telemedicine in post-treatment cancer survivorship care: an overview of systematic reviews. Annals of Oncology. 32(12). 1552–1570.
13.
Kumar, Sushant, Sarbari Ghosh, Alka Dwivedi, et al.. (2020). The Th9 Axis Reduces the Oxidative Stress and Promotes the Survival of Malignant T Cells in Cutaneous T-Cell Lymphoma Patients. Molecular Cancer Research. 18(4). 657–668.
14.
Tembhare, Prashant, Gaurav Chatterjee, Sitaram Ghogale, et al.. (2020). Flow cytometric evaluation of CD38 expression levels in the newly diagnosed T-cell acute lymphoblastic leukemia and the effect of chemotherapy on its expression in measurable residual disease, refractory disease and relapsed disease: an implication for anti-CD38 immunotherapy. Journal for ImmunoTherapy of Cancer. 8(1). e000630–e000630.
15.
Sethi, Nitin, et al.. (2020). Consensus Guidelines on Opening Up of Aesthetic Practices in India During the COVID-19 Era. SHILAP Revista de lepidopterología.
16.
Nayak, Lingaraj, Hasmukh Jain, Avinash Bonda, et al.. (2020). Hodgkin Lymphoma in Adolescent and Young Adults: Real-World Data from a Single Tertiary Cancer Center in India. Journal of Adolescent and Young Adult Oncology. 10(5). 581–587.
17.
Jain, H. K., Prashant Tembhare, Nikhil Patkar, et al.. (2020). Investigating the clinical, hematological and cytogenetic profile of endoreduplicated hypodiploids in BCP-ALL. Blood Cells Molecules and Diseases. 85. 102465–102465.
18.
Verma, Anuj, Sridhar Epari, Tejpal Gupta, et al.. (2020). Symptomatic Intracranial Rosai-Dorfman Disease in the Suprasellar Region Treated with Conformal Radiotherapy - A Report of Two Cases and Literature Review. Neurology India. 68(2). 489–489.
19.
Patkar, Nikhil, Prashant Tembhare, Hasmukh Jain, et al.. (2017). Immunogenetics of chronic lymphocytic leukemia. Indian Journal of Pathology and Microbiology. 60(1). 38–38.
20.
Jain, Avani, et al.. (2015). Contrast-enhanced [18F] fluorodeoxyglucose-positron emission tomography-computed tomography as an initial imaging modality in patients presenting with metastatic malignancy of undefined primary origin. Indian Journal of Nuclear Medicine. 30(3). 213–213.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Tianyou Wang Breakdown of academic impact, for papers by Ladislav Jebavý Breakdown of academic impact, for papers by Áurea Lima Breakdown of academic impact, for papers by Mohammad Vaezi Breakdown of academic impact, for papers by Edyta Szymańska Breakdown of academic impact, for papers by Sunday Ocheni Breakdown of academic impact, for papers by Geetha Narayanan Breakdown of academic impact, for papers by Riad El Fakih Breakdown of academic impact, for papers by Anand Patel Breakdown of academic impact, for papers by Yoo Jin Lee